Literature DB >> 12724566

Experimental infection of equine herpesvirus 9 in dogs.

T Yanai1, N Fujishima, H Fukushi, A Hirata, H Sakai, T Masegi.   

Abstract

Equine herpesvirus 9 (EHV-9), a new neurotropic equine herpesvirus, was inoculated intranasally at 107 plaque-forming units in five dogs to assess its pathogenicity. Dogs showed weight loss, pyrexia, anorexia, and neurologic signs on the fourth day. The EHV-9 virus was recovered from the examined brains. Histologically, dogs had a fulminant nonsuppurative encephalitis characterized by severe neuronal degeneration and loss, with intranuclear inclusions, slight glial reactions, perivascular cuffing, and multifocal hemorrhage. The olfactory bulb and the frontal and temporal lobes were predominantly affected. Immunohistochemistry revealed reactivity for EHV-9 antigen in neurons. All dogs had mild bronchopneumonia and various degrees of lymphoid necrosis. These findings indicate that dogs are fully susceptible to EHV-9 and that EHV-9 can cause fulminant encephalitis with high mortality in dogs, as in gazelles and goats.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12724566     DOI: 10.1354/vp.40-3-263

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  8 in total

1.  Experimental intranasal infection of equine herpesvirus 9 (EHV-9) in suckling hamsters: kinetics of viral transmission and inflammation in the nasal cavity and brain.

Authors:  Nagwan El-Habashi; El-Shaymaa El-Nahass; Hideto Fukushi; Daisuke Hibi; Hiroki Sakai; Vito Sasseville; Tokuma Yanai
Journal:  J Neurovirol       Date:  2010-05       Impact factor: 2.643

Review 2.  Olfactory transmission of neurotropic viruses.

Authors:  Isamu Mori; Yukihiro Nishiyama; Takashi Yokochi; Yoshinobu Kimura
Journal:  J Neurovirol       Date:  2005-04       Impact factor: 2.643

3.  Complete genome sequence of equine herpesvirus type 9.

Authors:  Hideto Fukushi; Tsuyoshi Yamaguchi; Souichi Yamada
Journal:  J Virol       Date:  2012-12       Impact factor: 5.103

4.  Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): infection with Equine Herpesvirus-1.

Authors:  Søren Saxmose Nielsen; Julio Alvarez; Dominique Joseph Bicout; Paolo Calistri; Elisabetta Canali; Julian Ashley Drewe; Bruno Garin-Bastuji; José Luis Gonzales Rojas; Christian Gortázar; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Helen Clare Roberts; Barbara Padalino; Paolo Pasquali; Hans Spoolder; Karl Ståhl; Antonio Velarde Calvo; Arvo Viltrop; Christoph Winckler; Andrea Carvelli; Romain Paillot; Alessandro Broglia; Lisa Kohnle; Francesca Baldinelli; Yves Van der Stede
Journal:  EFSA J       Date:  2022-01-12

5.  Comprehensive Serology Based on a Peptide ELISA to Assess the Prevalence of Closely Related Equine Herpesviruses in Zoo and Wild Animals.

Authors:  Azza Abdelgawad; Robert Hermes; Armando Damiani; Benjamin Lamglait; Gábor Á Czirják; Marion East; Ortwin Aschenborn; Christian Wenker; Samy Kasem; Nikolaus Osterrieder; Alex D Greenwood
Journal:  PLoS One       Date:  2015-09-17       Impact factor: 3.240

6.  Effect of a single point mutation on equine herpes virus 9 (EHV-9) neuropathogenicity after intranasal inoculation in a hamster model.

Authors:  Asmaa G Saleh; Shehata I Anwar; Osama M Abas; Hoda A Abd-Ellatieff; Mohamed Nasr; Ibrahim Saleh; Hideto Fukushi; Tokuma Yanai
Journal:  J Vet Med Sci       Date:  2017-07-15       Impact factor: 1.267

7.  New hosts for equine herpesvirus 9.

Authors:  Mark D Schrenzel; Tammy A Tucker; Taryn A Donovan; Martin D M Busch; Annabel G Wise; Roger K Maes; Matti Kiupel
Journal:  Emerg Infect Dis       Date:  2008-10       Impact factor: 6.883

8.  Zebra Alphaherpesviruses (EHV-1 and EHV-9): Genetic Diversity, Latency and Co-Infections.

Authors:  Azza Abdelgawad; Armando Damiani; Simon Y W Ho; Günter Strauss; Claudia A Szentiks; Marion L East; Nikolaus Osterrieder; Alex D Greenwood
Journal:  Viruses       Date:  2016-09-20       Impact factor: 5.048

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.